| 000 | 01675 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514034050.0 | ||
| 264 | 0 | _c20020724 | |
| 008 | 200207s 0 0 eng d | ||
| 022 | _a0143-5221 | ||
| 024 | 7 |
_a10.1042/ _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRademaker, Miriam T | |
| 245 | 0 | 0 |
_aCombined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure. _h[electronic resource] |
| 260 |
_bClinical science (London, England : 1979) _cJun 2002 |
||
| 300 |
_a653-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdrenomedullin |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCaptopril _xtherapeutic use |
| 650 | 0 | 4 |
_aCardiotonic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCreatinine _xurine |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aPeptides _xtherapeutic use |
| 650 | 0 | 4 |
_aPotassium _xurine |
| 650 | 0 | 4 | _aSheep |
| 650 | 0 | 4 |
_aSodium _xurine |
| 650 | 0 | 4 |
_aVasodilator Agents _xtherapeutic use |
| 700 | 1 | _aCharles, Chris J | |
| 700 | 1 | _aCooper, Garth J S | |
| 700 | 1 | _aCoy, David H | |
| 700 | 1 | _aEspiner, Eric A | |
| 700 | 1 | _aLewis, Lynley K | |
| 700 | 1 | _aNicholls, M Gary | |
| 700 | 1 | _aRichards, A Mark | |
| 773 | 0 |
_tClinical science (London, England : 1979) _gvol. 102 _gno. 6 _gp. 653-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1042/ _zAvailable from publisher's website |
| 999 |
_c11945948 _d11945948 |
||